Quel est le prix pour Aarti Pharmalabs Limited (AARTIPHARM)

Le prix pour Aarti Pharmalabs Limited (AARTIPHARM) est $9.28

Quelle est la capitalisation boursière pour Aarti Pharmalabs Limited (AARTIPHARM)

La capitalisation boursière pour Aarti Pharmalabs Limited (AARTIPHARM) est $841.31M

Aarti Pharmalabs Limited (AARTIPHARM) Prix et Capitalisation Boursière

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Prix pour AARTIPHARM	L’actif B	La capitalisation boursière de B	Résultats
$58,048.95 $841.31M	NVDA	$5.264T	+625,571.60%
$51,844.79 $841.31M	AAPL	$4.701T	+558,701.05%
$46,065.13 $841.31M	GOOG	$4.177T	+496,405.92%
$42,097.58 $841.31M	MSFT	$3.817T	+453,642.30%
$31,609.43 $841.31M	AMZN	$2.866T	+340,597.31%

Prix pour AARTIPHARM

L’actif B

La capitalisation boursière de B

Résultats

$58,048.95 $841.31M